Alvotech Valuation
| ALVO Stock | USD 5.12 0.13 2.61% |
At this time, the firm appears to be undervalued. Alvotech shows a prevailing Real Value of $9.18 per share. The current price of the firm is $5.12. Our model approximates the value of Alvotech from analyzing the firm fundamentals such as Shares Outstanding of 311.6 M, operating margin of (0.03) %, and Return On Asset of 0.0198 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Alvotech's valuation include:
Enterprise Value | Enterprise Value Ebitda 24.8542 | Price Sales 2.7826 | Forward PE 10.352 | Trailing PE 22.2609 |
Undervalued
Today
Please note that Alvotech's price fluctuation is somewhat reliable at this time. Calculation of the real value of Alvotech is based on 3 months time horizon. Increasing Alvotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Alvotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Alvotech Stock. However, Alvotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.12 | Real 9.18 | Target 22.17 | Hype 5.11 | Naive 4.85 |
The intrinsic value of Alvotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Alvotech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Alvotech helps investors to forecast how Alvotech stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Alvotech more accurately as focusing exclusively on Alvotech's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Alvotech's intrinsic value based on its ongoing forecasts of Alvotech's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Alvotech's closest peers.
Alvotech Cash |
|
Alvotech Total Value Analysis
Alvotech is presently anticipated to have valuation of 2.83 B with market capitalization of 1.6 B, debt of 1.19 B, and cash on hands of 128.44 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Alvotech fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.83 B | 1.6 B | 1.19 B | 128.44 M |
Alvotech Investor Information
About 62.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Alvotech may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.Alvotech Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Alvotech has an asset utilization ratio of 40.09 percent. This suggests that the Company is making $0.4 for each dollar of assets. An increasing asset utilization means that Alvotech is more efficient with each dollar of assets it utilizes for everyday operations.Alvotech Profitability Analysis
Considering the key profitability indicators obtained from Alvotech's historical financial statements, Alvotech may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Alvotech's ability to earn profits and add value for shareholders.Net Loss | First Reported 2019-03-31 | Previous Quarter 32 M | Current Value -5.2 M | Quarterly Volatility 130.6 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Return On Equity | 0.48 | 0.51 |
|
|
For Alvotech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Alvotech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Alvotech utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Alvotech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Alvotech over time as well as its relative position and ranking within its peers.
Alvotech Earnings per Share Projection vs Actual
The next projected EPS of Alvotech is estimated to be 0.08585 with future projections ranging from a low of 0.02275 to a high of 0.16. Alvotech's most recent 12-month trailing earnings per share (EPS TTM) is at 0.23. Please be aware that the consensus of earnings estimates for Alvotech is based on EPS before non-recurring items and includes expenses related to employee stock options.Alvotech Earnings Estimation Breakdown
The calculation of Alvotech's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Alvotech is estimated to be 0.08585 with the future projection ranging from a low of 0.02275 to a high of 0.16. Please be aware that this consensus of annual earnings estimates for Alvotech is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.02 Lowest | Expected EPS | 0.16 Highest |
Alvotech Earnings Projection Consensus
Suppose the current estimates of Alvotech's value are higher than the current market price of the Alvotech stock. In this case, investors may conclude that Alvotech is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Alvotech's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 6 | 17.52% | 0.0 | 0.08585 | 0.23 |
Alvotech Ownership Allocation
Alvotech holds a total of 311.6 Million outstanding shares. Alvotech shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 61.76 percent of Alvotech outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Alvotech Profitability Analysis
The company reported the previous year's revenue of 489.68 M. Net Loss for the year was (231.86 M) with profit before overhead, payroll, taxes, and interest of 318.74 M.About Alvotech Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Alvotech. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Alvotech based exclusively on its fundamental and basic technical indicators. By analyzing Alvotech's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Alvotech's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Alvotech. We calculate exposure to Alvotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Alvotech's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 350 M | 367.5 M | |
| Pretax Profit Margin | (0.40) | (0.42) | |
| Operating Profit Margin | 0.14 | 0.13 | |
| Net Loss | (0.43) | (0.45) | |
| Gross Profit Margin | 0.56 | 0.59 |
Alvotech Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 267.9 M | |
| Quarterly Earnings Growth Y O Y | -0.584 | |
| Forward Price Earnings | 10.352 |
Alvotech Current Valuation Indicators
Alvotech's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Alvotech's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Alvotech, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Alvotech's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Alvotech's worth.When determining whether Alvotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alvotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alvotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alvotech Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alvotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Will Biotechnology sector continue expanding? Could Alvotech diversify its offerings? Factors like these will boost the valuation of Alvotech. If investors know Alvotech will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Alvotech data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.58) | Earnings Share 0.23 | Revenue Per Share | Quarterly Revenue Growth 0.106 | Return On Assets |
Understanding Alvotech requires distinguishing between market price and book value, where the latter reflects Alvotech's accounting equity. The concept of intrinsic value - what Alvotech's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Alvotech's price substantially above or below its fundamental value.
Understanding that Alvotech's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Alvotech represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Alvotech's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.